[過去ﾛｸﾞ] 【4565】そーせいG 437 【第3四半期決算発表2月14日予定】 (812ﾚｽ)
上下前次1-新

---

このｽﾚｯﾄﾞは過去ﾛｸﾞ倉庫に格納されています｡
次ｽﾚ検索 歴削→次ｽﾚ 栞削→次ｽﾚ 過去ﾛｸﾞﾒﾆｭｰ

---

811: (ﾜｯﾁｮｲ b78e-K9Vl) 2018/02/20(火)17:35 ID:RAsWa/Kl0(12/12) AA×


[240|320|480|600|100%|JPG|べ|ﾚｽ栞|ﾚｽ消]
811: (ﾜｯﾁｮｲ b78e-K9Vl) [] 2018/02/20(火) 17:35:36.90 ID:RAsWa/Kl0 Acknowledgements: ・This work was funded by a grant from the European Research Council (EMPSI 339995) Heptares Therapeutics Ltd, Pfizer and core funding from the Medical Research Council [MRC U105197215]. ・We thank Rishi Matadeen and Kasim Sader for their help with cryo EM data collection, Christos Savva for his help in using the VPP and Wim Hagen for the SerialEM single-particle data collection script. ・We also thank Rafael Fernandez-Leiro, Sjors Scheres and Paula da Fonseca for useful discussions. Competing financial interests: ・CGT is a consultant and shareholder of Heptares Therapeutics, and they also funded this work. http://hayabusa9.5ch.net/test/read.cgi/livemarket1/1517924072/811

---

上下前次1-新書関写板覧索設栞歴

---

あと 1 ﾚｽあります
ｽﾚ情報 赤ﾚｽ抽出 画像ﾚｽ抽出 歴の未読ｽﾚ AAｻﾑﾈｲﾙ

---

ぬこの手 ぬこTOP 0.128s*